Association between side effects of oral anti-diabetic drugs and self-reported mental health and quality of life among patients with type 2 diabetes

National Medical Journal of China

Volumn 91, Issue 4, 2011, Pages 229-233

  Chen, Zong Cun ^a   Zhang, Shao Ling ^a   Yan, Li ^a   Wu, Mu Chao ^a   Chen, Li Hong ^a   Ji, Li Nong ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Diabetes mellitus, type 2; Hypoglycaemia; Mental health

Indexed keywords

ORAL ANTIDIABETIC AGENT; ANTIDIABETIC AGENT;

ADULT; ARTICLE; CHINA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EUROQOL 5D; FOLLOW UP; HUMAN; HYPOGLYCEMIA; HYPOGLYCEMIA FEAR SURVEY II; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MENTAL HEALTH; MONOTHERAPY; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; QUALITY OF LIFE; RATING SCALE; SCORING SYSTEM; SELF REPORT; SIDE EFFECT; SYMPTOM; TREATMENT DURATION; WEIGHT GAIN; AGED; ATTITUDE TO HEALTH; CLINICAL TRIAL; FEMALE; MIDDLE AGED; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RETROSPECTIVE STUDY;

AGED; ATTITUDE TO HEALTH; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MENTAL HEALTH; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; RETROSPECTIVE STUDIES;

EID: 84869233629     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2011.04.004     Document Type: Article

References (22)

1. Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med, 2010, 362:1090-1101.
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 1998, 352:837-853.
3. Ray K K, Seshasai S R, Wijesuriya S, et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet, 2009, 373:1765-1772.
4. Koro C E, Bowlin S J, Bourgeois N, et al. Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care, 2004, 27:17-20.
5. Cryer P E. The barrier of hypoglycemia in diabetes. Diabetes, 2008, 57:3169-3176.
6. Alvarez G F, Tofe P S, Krishnarajah G, et al. Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study. Diabetes Obes Metab, 2008, 10(Suppl 1).25-32.
7. Dennett S L, Boye K S, Yurgin N R. The impact of body weight on patient utilities with or without type 2 diabetes: a review of the medical literature. Value Health, 2008, 11:478-486.
8. Maggio C A, Pi-Sunyer F X. Obesity and type 2 diabetes. Endocrinol Metab Clin North Am, 2003, 32:805-822.
9. Cox D J, Irvine A, Gonder-Frederick L, et al. Fear of hypoglycemia: quantification, validation, and utilization. Diabetes Care, 1987, 10:617-621.
10. Irvine A A, Cox D, Gonder-Frederick L. Fear of hypoglycemia: relationship to physical and psychological symptoms in patients with insulin-dependent diabetes mellitus. Health Psychol, 1992, 11:135-138.
11. The EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy, 1990, 16:199-208.
12. Brazier J, Jones N, Kind P. Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire. Qual Life Res, 1993, 2:169-180.
13. Sakamaki H, Ikeda S, Ikegami N, et al. Measurement of HRQL using EQ-5D in patients with type 2 diabetes mellitus in Japan. Value Health, 2006, 9:47-53.
14. Grandy S, Fox K M. EQ-5D visual analog scale and utility index values in individuals with diabetes and at risk for diabetes: Findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD). Health Qual Life Outcomes, 2008, 27:6-18.
15. 2009, 2:12-18.
16. Vexiau P, Mavros P, Krishnarajah G, et al. Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France. Diabetes Obes Metab, 2008, 10(Suppl 1): 16-24.
17. Wild D, von Maltzahn R, Brohan E, et al. A critical review of the literature on fear of hypoglycemia in diabetes; implications for diabetes management and patient education. Patient Educ Couns, 2007, 68:10-15.
18. Gerstein H C, Miller M E, Byington R P, et al. Action to control cardiovascular risk in diabetes study group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med, 2008, 358: 2545-2559.
19. Patel A, MacMahon S, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med, 2008, 358:2560-2572.
20. Duckworth W, Abraira C, Moritz T, et al. VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med, 2009, 360:129-139.
21. Brod M, Cobden D, Lammert M, et al. Examining correlates of treatment satisfaction for injectable insulin in type 2 diabetes; lessons learned from a clinical trial comparing biphasic and basal analogues. Health Qual Life Outcomes, 2007, 7: 5-8.
22. Marrett E, Stargardt T, Mavros P, et al. Patient-reported outcomes in a survey of patients treated with oral antihyperglycaemic medications; associations with hypoglycaemia and weight gain. Diabetes Obes Metab, 2009, 11:1138-1144.